Roche Launches New Elevidys Study After Feedback From European ...

Roche Restarts Phase III Trial for Elevidys to Secure EMA Approval

New Delhi: Roche on Thursday said it is initiating a late stage study for its gene therapy ​Elevidys following feedback from the European drug regulator. The ‌therapy for duchenne muscular dystrophy...

Roche to start new Elevidys study following setback in Europe

The Swiss drugmaker, which owns rights to the Duchenne gene therapy outside the U.S., hopes the trial will yield additional approvals in Europe and elsewhere.

Roche launches new Elevidys study after feedback from European ...

Roche to launch another Elevidys trial, with eyes on European approval

European regulators last year said the Duchenne gene therapy, which is sold by Sarepta in the U.S., failed to show clear benefits.

Roche to launch global study of Elevidys following EU rejection

Roche will be launching the Phase III trial to gain approval of Elevidys in Europe and other countries globally.The post Roche to launch global study of Elevidys following EU rejection appeared first on Clinical Trials Arena.

Roche to start a new Phase 3 trial for Elevidys after getting rebuffed by EU regulator last year

Roche said it will run a new Phase 3 trial for the controversial Duchenne muscular dystrophy gene therapy Elevidys in another attempt to win approval for the therapy in Europe and other regions. The